Literature DB >> 20538093

"Fitness for duty": social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs.

Carla Treloar1, Paul Byron, Pol McCann, Lisa Maher.   

Abstract

Several candidate vaccines for hepatitis C are currently in preclinical development or the early stages of clinical trials. Implementing trials of these vaccines among people who inject drugs will be challenging. Previous research, particularly willingness to participate studies in relation to HIV vaccines in marginalized groups, has focused on the modifiable characteristics of individual participants. This qualitative research with people who inject drugs, health staff and clinicians focuses on social, organisational and structural elements of vaccine trial designs which may exclude or reduce the participation of people who inject drugs. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538093     DOI: 10.1016/j.vaccine.2010.05.064

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities.

Authors:  Lisa Maher; Bethany White; Margaret Hellard; Annie Madden; Maria Prins; Thomas Kerr; Kimberly Page
Journal:  Vaccine       Date:  2010-09-09       Impact factor: 3.641

2.  Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment.

Authors:  April M Young; Dustin B Stephens; Hanan A Khaleel; Jennifer R Havens
Journal:  Contemp Clin Trials       Date:  2014-12-30       Impact factor: 2.226

3.  Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs.

Authors:  Bethany White; Annie Madden; Margaret Hellard; Thomas Kerr; Maria Prins; Kimberly Page; Gregory J Dore; Lisa Maher
Journal:  Drug Alcohol Rev       Date:  2012-11-01

4.  Trust in research physicians as a key dimension of randomized controlled trial participation in clinical addictions research.

Authors:  Kaitlyn Jaffe; Ekaterina Nosova; Kora DeBeck; Kanna Hayashi; M-J Milloy; Lindsey Richardson
Journal:  Subst Abus       Date:  2021-03-22       Impact factor: 3.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.